Hereditary Transthyretin Amyloidosis Neuropathy Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
Hereditary Transthyretin Amyloidosis Neuropathy Medications, Costs & Savings
Pharmacist insight
Anti-seizure medications require careful monitoring of blood levels to ensure therapeutic effectiveness. I advise patients never to switch between brand and generic without consulting their pharmacist, as even small differences in absorption can affect seizure control. Medication adherence is the single most important factor.
Angela C. Beverly, PharmD
About Hereditary Transthyretin Amyloidosis Neuropathy
Hereditary transthyretin amyloidosis neuropathy (hATTR-PN) is a rare, progressive genetic disorder that damages nerves and other organs. While treatments can significantly slow its progression, the cost of these specialized medications can be a major barrier. TheDrugClub helps make these life-changing prescriptions more accessible and affordable for individuals and families facing hATTR-PN.
Hereditary transthyretin amyloidosis neuropathy (hATTR-PN) is a serious, inherited condition caused by a mutation in the transthyretin (TTR) gene. This genetic flaw leads to the production of unstable, misfolded TTR proteins. Instead of circulating normally, these abnormal proteins accumulate as amyloid fibrils, primarily depositing in the peripheral and autonomic nerves, but also in other organs like the heart, kidneys, and eyes.
Over time, these amyloid deposits disrupt normal nerve function, leading to a range of debilitating symptoms. Patients often experience progressive peripheral neuropathy, characterized by numbness, tingling, pain, and weakness, particularly in the hands and feet. Autonomic neuropathy can cause digestive issues, low blood pressure, sexual dysfunction, and problems with bladder control. Carpal tunnel syndrome is also common. Without treatment, hATTR-PN is a progressive and often fatal condition, impacting quality of life significantly.
Common Treatments and Medications for hATTR-PN
The good news is that advancements in medicine have led to effective treatments that can slow or even halt the progression of hATTR-PN. These treatments primarily fall into two categories:
1. TTR Stabilizers: Medications like tafamidis (Vyndaqel, Vyndamax) work by stabilizing the TTR protein, preventing it from misfolding and forming amyloid deposits. 2. Gene Silencers: These therapies, including patisiran (Onpattro), inotersen (Tegsedi), and vutrisiran (Amvuttra), reduce the production of TTR protein in the liver, thereby decreasing the amount of amyloid-forming protein in the body.
While these medications offer hope and improved outcomes, they are often specialty drugs with very high price tags, posing a significant financial burden for many patients.
How TheDrugClub Helps You Save on Prescriptions
At TheDrugClub, we understand that access to essential medications shouldn't be limited by cost. Our membership program is designed to help you save on your prescriptions, including the specialized drugs used to treat hATTR
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.